Skip to main content
Log in

Agencies consider multiple factors when ICERs above thresholds

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Griffiths EA, et al. Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold. ClinicoEconomics and Outcomes Research 7: 463-76, 31 Aug 2015. Available from: URL: http://dx.doi.org/10.2147/CEOR.S87462

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agencies consider multiple factors when ICERs above thresholds. PharmacoEcon Outcomes News 737, 8 (2015). https://doi.org/10.1007/s40274-015-2454-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2454-6

Navigation